Daniel Steiner

Company: Molecular Partners AG

Job title: Senior Vice President Research & Technology

Seminars:

Uncovering Novel Radiopharmaceutical Targets DLL3 2:30 pm

Uncovering targeting potential Preclinical insights Treatment potential for tough to treat lung cancerRead more

day: Conference Day Two

Expanding Radiopharmaceutical Targeting Mechanisms with Novel Moieties to Harness Enhanced Specificity, Efficacy & Safety 11:00 am

The development of novel targeting moieties for radiopharmaceuticals has seen significant advancements, particularly in the context of targeting cancer cells and supporting tissues. These novel moieties include small peptides, cyclic peptides, bispecifics and nanobodies, each offering unique advantages in terms of specificity, stability, and pharmacokinetics. Uncovering the latest understandings and developments across novel targeting approaches,…Read more

day: Workshop B